.jpg)
.jpg)
October 18, 202410:23 PM GMT+7
KIBATI, Democratic Republic of Congo, Oct 18 (Reuters) - Congo needs to do more to raise awareness about mpox and the availability of vaccines, an official with the response team said on Thursday, warning the campaign to distribute the shots would take longer than anticipated
Congo's mpox vaccination campaign launched this month in the hard-hit east. A Reuters reporter at a vaccination site in North Kivu province found that locals seemed unaware or suspicious of the shots.
Cris Kacita, the head of Congo's mpox response team, said more needed to be done to boost vaccine uptake, adding that the ongoing vaccination campaign would last longer than the planned 10 days.
"The awareness campaign has been carried out, but only timidly. These are gaps that need to be filled," he told Reuters.
During a recent visit to a vaccination site in Kibati, a camp that hosts displaced people in North Kivu province, residents described receiving no information about the inoculation efforts.
"I know nothing about this vaccine. No one has come to educate me about any vaccination against mpox," Simon Ngagijimana Chui, the camp chief, said.
Congo's mpox vaccination campaign is a key step in efforts to contain the outbreak at its epicentre, from where it has spread to numerous other African nations this year.
The campaign's scope has been narrow to start due to limited supply, with just 265,000 doses currently available in the country of around 100 million people.
Health workers in Kibati have recruited local advocates who have been vaccinated and are trusted by the community to promote the benefits.
Item 1 of 3 A Congolese health official administers a mpox vaccination to a man, a key step in efforts to contain an outbreak that has spread from its epicentre, at a hospital in Goma, North Kivu province, Democratic Republic of Congo October 5, 2024. REUTERS/Stringer/File Photo
A Congolese health official administers a mpox vaccination to a man, a key step in efforts to contain an outbreak that has spread from its epicentre, at a hospital in Goma, North Kivu province, Democratic Republic of Congo October 5, 2024. REUTERS/Stringer/File Photo Purchase Licensing Rights, opens new tab
One of them is Benire Furahini Buchaguzi, 22, who uses a loudspeaker to spread her message.
"I bring my vaccination certificate to the community to show them that I have received my vaccine and to encourage them," she said.
Mpox can spread through close contact and typically causes flu-like symptoms and pus-filled lesions on the body. While usually mild, it can be fatal.
Florence Frebo Uwimana, a young mother listening to Buchaguzi, said it was the first she had heard of the vaccination campaign.
"They just tell us to quickly bring anyone showing symptoms to the hospital, but no one talks to us about the vaccine," she said.
Africa has reported over 42,400 suspected and confirmed mpox cases and 1,100 deaths since the start of 2024, the Africa Centres for Disease Control and Prevention said on Thursday. The vast majority of these have been in Congo.
In Goma, the provincial capital, healthcare workers are concerned the lack of information will undermine efforts to contain the disease.
"Perhaps they haven't been informed about this vaccine," said Dr. Hassan Amisi Djuma, a public health expert working in the city.
"If the population hasn't been informed about a disease, the risk is it may spread among them."
The Reuters Daily Briefing newsletter provides all the news you need to start your day. Sign up here.
Additional reporting by Sonia Rolley and Anait Miridzhanian; Writing by Jessica Donati; Editing by Bill Berkrot
Комментарии